Answers are grounded in this paper and cite their sources.
The ctDNA assay demonstrates high accuracy and specificity, for both prevalent and rare genetic alterations. While further advancements are needed to enhance sensitivity and routine clinical application, our ctDNA profiling assay offers a reliable alternative for detecting genetic alterations in lung cancer patients, with significant potential for clinical integration in the Indian healthcare context.
No takes yet. Share an insight, caveat, or question.
Jha et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: